The sources of back pain may be myogenic dysfunction, intervertebral disc pathology or osteoarthritis of the archicular (facet) joints of the spine, including myofascial pain syndrome.  A differentiated approach to the treatment of spondylarthrosis is still an unsolved problem.
Special attention is paid to SYSADOA group chemicals, in particular chondroitin sulfate (mucosat).  These drugs have proven analgesic and anti-inflammatory effects and also are able to improve the structure of the cartilaginous tissue, slowing the progression of the disease.
